Showing 1 - 2 results of 2 for search 'D. Brander', query time: 0.02s Refine Results
  1. 1
    P682: NEMTABRUTINIB (MK-1026), A NON-COVALENT INHIBITOR OF WILD-TYPE AND C481S MUTATED BRUTON TYROSINE KINASE FOR B-CELL MALIGNANCIES: EFFICACY AND SAFETY OF THE PHASE 2 DOSE-EXPANSION BELLWAVE-001 STUDY

    P682: NEMTABRUTINIB (MK-1026), A NON-COVALENT INHIBITOR OF WILD-TYPE AND C481S MUTATED BRUTON TYROSINE KINASE FOR B-CELL MALIGNANCIES: EFFICACY AND SAFETY OF THE PHASE 2 DOSE-EXPAN... by J. Woyach, I. W. Flinn, F. T. Awan, H. Eradat, D. Brander, M. Tees, S. A. Parikh, T. Phillips, W. Wang, N. M. Reddy, M. Z. Farooqui, J. C. Byrd, D. M. Stephens

    Published 2022-06-01
    Get full text
    Article
  2. 2
    P674: UPDATED RESULTS OF A PHASE 1B STUDY OF IBRUTINIB (IBR) PLUS OBINUTUZUMAB (OBIN) IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

    P674: UPDATED RESULTS OF A PHASE 1B STUDY OF IBRUTINIB (IBR) PLUS OBINUTUZUMAB (OBIN) IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) by C. Ryan, D. Brander, P. Barr, S. Tyekucheva, Y. Ren, L. Hackett, M. McDonough, K. Pena Del Aguila, M. McEwan, M. Collins, J. Abramson, E. Jacobsen, A. LaCasce, D. Fisher, J. Brown, M. Davids

    Published 2022-06-01
    Get full text
    Article

Search Tools: